Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/2/2025

Management of Low Free Testosterone with Normal Total Testosterone

Diagnostic Considerations

  • The American College of Gastroenterology recommends measuring morning total testosterone to confirm it is truly in the normal range, along with free testosterone by equilibrium dialysis and sex hormone-binding globulin (SHBG) to understand binding dynamics 1
  • The Endocrine Society suggests measuring serum luteinizing hormone (LH) to establish whether this represents secondary hypogonadism, with guidance from The Journal of Urology 2

Treatment Decision Algorithm

  • The American Urological Association indicates that initiation of testosterone replacement therapy should be based on confirmed low free testosterone and presence of hypogonadal symptoms, as suggested by Praxis Medical Insights 3
  • For men wishing to preserve fertility, The Journal of Urology recommends considering selective estrogen receptor modulators (SERMs) like clomiphene citrate rather than testosterone replacement 2

Special Considerations

  • The Obesity Society notes that in obese men, increased aromatization of testosterone to estradiol in adipose tissue causes estradiol-mediated negative feedback that suppresses pituitary LH secretion, as reported in Gastroenterology 1
  • Weight loss can improve functional hypogonadism in obese men, with lifestyle modifications emphasized alongside hormonal therapy, according to Praxis Medical Insights 4

Monitoring Protocol

  • The American College of Physicians recommends initial follow-up at 1-2 months to assess efficacy and consider dose adjustments, with subsequent visits at 3-6 month intervals for the first year, as outlined by Praxis Medical Insights 3
  • At each visit, assess symptomatic response to treatment, voiding symptoms, sleep apnea symptoms, digital rectal examination, serum testosterone levels, PSA levels, and hematocrit or hemoglobin, as suggested by Praxis Medical Insights 3

Hypogonadism Diagnosis and Treatment

Laboratory Findings

  • The patient's DHEA level of 155.9 μg/dL is within normal range, suggesting adrenal androgen production is intact, according to the Gut journal 5
  • The patient's progesterone level of 0.8 ng/mL is within normal male range, which is expected, as reported in the Gut journal 5
  • Low SHBG levels, such as 14.20 nmol/L, are typically reduced in conditions like obesity or metabolic syndrome, as noted in the Gut journal 5

Diagnostic Steps

  • Repeat morning total testosterone measurement is essential to confirm levels remain below 300 ng/dL on two separate occasions, as recommended by the Gut journal 5
  • Measuring serum LH and FSH helps distinguish between primary hypogonadism and secondary hypogonadism, according to The Journal of Urology 6
  • Checking prolactin levels is necessary to exclude hyperprolactinemia as a reversible cause of secondary hypogonadism, as suggested by The Journal of Urology 6
  • Assessing thyroid function, including TSH and free T4, is crucial, as thyroid disorders can affect sex hormone metabolism, as reported in the Gut journal 5

Treatment Considerations

  • If fertility is a concern, testosterone monotherapy should not be prescribed, as it suppresses spermatogenesis, according to The Journal of Urology 6
  • Selective estrogen receptor modulators like clomiphene citrate may be considered as first-line therapy to stimulate endogenous testosterone production while preserving fertility, as recommended by The Journal of Urology 6
  • Weight loss is more effective than aromatase inhibitors for managing estradiol in obese men, as it reduces adipose tissue aromatization, as noted in the Gut journal 5